Stanford Blood Center Launches Infectious Disease Testing for Organ and Tissue Donors
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
Doing more with less. That’s the challenge all labs and blood banks face today, thanks to a combination of factors. With the pressure on, it’s easy to fall into a pattern of simply keeping up—or attempting to keep up—and never addressing the issues at hand.
The company’s GX Solutions are designed for critical healthcare applications and offer optimized control of temperature management, noise management, and energy management.
The American Red Cross laboratory in Charlotte, NC, is now screening blood samples collected in the states of New Hampshire, New Jersey, Maine, Maryland, Pennsylvania, and Vermont, using the Procleix Babesia assay under an investigational new drug study.
Read MoreThis month’s issue features hematology, blood banking, and organ transplantation products from such companies as Abbott, Advanced Instruments, Helmer Scientific, and Ortho Clinical Diagnostics.
Read MoreBlood bank analytics are critical both for feeding back their results to clinicians so that they can improve their transfusion prescribing practices, and for demonstrating to program executives where progress has been made.
Read MoreLines of communication between blood banks and the clinical lab, as well as with the clinical service lines in other departments, are crucial.
Read MoreIn recent years, challenges to the safety of the nation’s blood supply include a rising understanding of the risks involved in blood transfusions, threats related to known infectious diseases, and the emergence of new pathogens.
Read MoreThe program provides traditional onsite support and consulting, and predictive, connected technologies.
Read MoreThis month’s Product Spotlight features tools for hematology, blood banking, and biorepositories from such companies as Beckman Coulter, Hemo Bioscience, Ortho Clinical Diagnostics, and Sebia.
Read MoreValGenesis seeks to ensure that data created, modified, and stored within its blood banking application are capable of passing internal and regulatory audits, while improving the overall efficiency of validation programs for blood services centers.
Read MoreThe new release aims to simplify blood banking administration through improved integration with enterprise electronic health records.
Read MoreThe company reports that clinical trials using its MosaiQ transfusion diagnostic instrument and associated assays will begin later this year.
Read MoreMaking the transition from manual to automated blood analysis supports the hospital’s efforts to become a Level II trauma center.
Read MoreReasons for the blood supply’s safe levels include advances in donor screening, improved testing, automated data systems, and changes in transfusion medicine practices.
Read MoreThis month’s Product Spotlight features blood banking and biorepository tools from companies such as Beckman Coulter, Helmer, Thermo Fisher Scientific, and Wheaton.
Read MoreAn agreement between Quotient and OCD assigns MosaiQ commercialization rights in the global patient testing market and donor testing markets in the developing world and Japan, while accelerating launch of the MosaiQ system.
Read MoreNearly 5 million people in the United States receive blood transfusions each year, mainly with donations collected, separated, and stored at blood banks. These days both private and institutional blood banks and biobanks are attracting significant amounts of investment, but they’re also facing challenges.
Read More